Read about our latest pharmaceutical total synthesis under flow conditions here. Congrats to Chantal Scholtz on her development of an improved flow synthesis of the anti-inflammatory COX-2 inhibitor celecoxib.
Read about our latest pharmaceutical total synthesis under flow conditions here. Congrats to Chantal Scholtz on her development of an improved flow synthesis of the anti-inflammatory COX-2 inhibitor celecoxib.